1. What is CAM? National Center for Complementary and Alternative Medicine. National Institute of Health; National Center for Complementary and Alternative Medicine, National Institute of Health.
2. Kemper KJ, Vohra S, Walls R. American Academy of Pediatrics. The use of complementary and alternative medicine in pediatrics. Pediatrics 2008;122(6):1374–1386.
3. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2009;(12):1–23.
4.Salvioli GP. I pediatri Italiani e le medicine complementari. Pediatria 2011,1:4–5.
5. Davis MP, Darden PM. Use of complementary and alternative medicine by children in the United States. Arch Pediatr Adolesc Med 2003;157:393–6.
6. Ottolini MC, Hamburger EK, Loprieato JO, Coleman RH,Sachs HC, Madden R, et al. Complementary and alternative medicine use among children in the Washington, DC area. Ambul Pediatr 2001;1:122–5.
7. Simpson N, Pearce A, Finlay F, Lenton S. The use of complementary medicine in paediatric outpatient clinics. Ambul Child Health 1998;3:351–6.
8. Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, van der Wel M.Use of alternative treatment in pediatric oncology. Cancer Nurs 1998;21:282–8.
9. Stern RC, Canda ER, Doershuk CF. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health 1992;13:612–5.
10. Vlieger AM, Blink M, Tromp E, Benninga MA. Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey. Pediatrics 2008;122(2):e446–e451.
11. Day AS. Use of complementary and alternative therapies and probiotic agents by children attending gastroenterology outpatient clinics. J Paediatr Child Health 2002;38(4):343–346.
13. Perkin JM: Constipation in childhood: a controlled comparison between lactulose and standardized senna. Curr Med Res Opin 1977, 4:540-543.
14. Sondheimer JM, Gervaise EP: Lubricant versus laxative in the treatment of chronic functional constipation of children: a comparative study. JPediatr Gastroenterol Nutr 1982, 1:223-226.
15. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998;279:154853.
16. Bausell RB, Lee W, Berman BM. Demographic and health-related correlates of visits to complementary and alternative medical providers. Med Care 2001;39:190–196.
17. Eisenbeg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997. JAMA 1998;280:1569–75.
18. Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, van der Wel M. Use of alternative treatment in pediatric oncology. Cancer Nurs 1998;21:282–8.
19. Southwood TR, Malleson PN, Roberts-Thomson PJ, Mahy M. Unconventional remedies used for patients with juvenile arthritis. Pediatrics 1990;85:150–4
20. Stern RC, Canda ER, Doershuk CF. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health 1992;13:612–5.
21. McCann LJ, Newell SJ. Survey of paediatric complementary and alternative medicine use in health and chronic illness. Arch Dis Child 2006;91:173–174.
22. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28:255–81.
24. Fernandez CV, Stutzer CA, MacWilliam L, Fryer C
. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol 1998; 16:1279–86.
25. Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, van der Wel M
. Use of alternative treatment in pediatric oncology. Cancer Nurs 1998; 21:282–8.
26. Stern RC, Canda ER, Doershuk CF. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health 1992; 13:612–5.
27. Barnes, PM, Powell-Griner E, McFann K, Nahin RL. [Accessed May 25, 2008] CDC Advance Data Report No. 343. Complementary and alternative medicine use among adults: United States, 2002.
Centers for Disease Control and Prevention Website. http://nccam.nih.gov/news/report.pdf.
28. Hilsden RJ, Scott CM, Verhoef MJ. Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol 1998; 93:697–701.
29. Day AS, Whitten KE, Bohane TD. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. J Paediatr Child Health 2004; 40:681–4.
30. Heuschkel R, Afzal N, Wuerth A, Zurakowski D
, Leichtner A
, Kemper K
, et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 2002; 97:382–8.
31. Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, et al. Crocus sativus L.(saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG 2008; 115:515 - 9.
32. Cala S, Crismon ML, Baumgartner J. A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression. Pharmacotherapy 2003; 23: 222 -30.
33. Salehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A,et al. Ginkgo biloba for attentiondeficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial. Prog. Neuropsychopharmacol Biol. Psychiatry 2010; 34: 76 – 80.
34. Post-White J, Sencer S, Fitzgerald M. Complementary and alternative treatments in children with cancer. In: Kelly K, Baggott C, Foley G,editors. Nursing Care of the Child with Cancer. 2nd ed. Philadelphia:Saunders; 2003:256–263.
35. Post-White J, Hawks R. Complementary and alternative medicine in pediatric oncology. Sem Oncol Nurs 2005;21:107–114.
36. Post-White J. Complementary and alternative medicine in pediatric oncology. J Pediatr Oncol Nurs 2006;23:244–253.
37. Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 2010;125:768–776.